Kathmere Capital Management’s Gilead Sciences GILD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.82M	Sell	27,425 -822	-3%	-$115K	0.24%	82
2025 Q4	$3.47M	Buy	28,247 +1,758	+7%	+$214K	0.23%	79
2025 Q3	$2.94M	Buy	26,489 +1,510	+6%	+$172K	0.21%	89
2025 Q2	$2.77M	Buy	24,979 +3,149	+14%	+$335K	0.21%	88
2025 Q1	$2.45M	Buy	21,830 +4,303	+25%	+$444K	0.21%	82
2024 Q4	$1.62M	Buy	17,527 +5,246	+43%	+$472K	0.15%	97
2024 Q3	$1.03M	Buy	12,281 +2,266	+23%	+$173K	0.1%	128
2024 Q2	$687K	Buy	10,015 +7,051	+238%	+$471K	0.07%	146
2024 Q1	$217K	Buy	2,964 +460	+18%	+$35.4K	0.02%	299
2023 Q4	$203K	Buy	+2,504	New	+$195K	0.03%	278
2023 Q2	–	Sell	-2,776	Closed	-$230K	–	245
2023 Q1	$230K	Buy	+2,776	New	+$230K	0.04%	182